Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention

Introduction: There is some controversy over the efficacy of statins for the prevention of contrastinduced nephropathy (CIN). There have also been reports on varying efficacies of different statins. Hence, in this study the efficacy of atorvastatin and rosuvastatin for the prevention of CIN was asse...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Cardiovasc Thorac Res
Auteurs principaux: Firouzi, Ata, Kazem Moussavi, Ali, Mohebbi, Ahmad, Alemzadeh-Ansari, Mohammad Javad, Kiani, Reza, Sanati, Hamid Reza, Mohebbi, Bahram, Shakerian, Farshad, Zahedmehr, Ali, Ansari-Ramandi, Mohammad Mostafa, Oni Heris, Saeed, Ghaleshi, Bahar, Ghorbani, Fatemeh
Format: Artigo
Langue:Inglês
Publié: Tabriz University of Medical Sciences 2018
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6203872/
https://ncbi.nlm.nih.gov/pubmed/30386535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/jcvtr.2018.24
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires